SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026)
SELLAS Life Sciences (SLS) reported Treasury Shares of $3.8 million for Q3 2017, little changed year-over-year from $3.8 million in Q3 2016, and little changed quarter-over-quarter from $3.8 million in Q2 2017.
SELLAS Life Sciences (SLS) Treasury Shares (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has 8 years of Treasury Shares data on file, last reported at $3.8 million in Q3 2017.
- Treasury Shares for Q3 2017 came in at $3.8 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2017 was $3.8 million (changed 0.0% YoY), and the FY2016 annual result was $3.8 million, changed 0.0% from the prior year.
- Treasury Shares steadied at $3.8 million in Q3 2017 per SLS's latest filing, from $3.8 million in the prior quarter.
- Over five years, Treasury Shares peaked at $2.3 million in Q1 2026 and troughed at $255000.0 in Q4 2022.
- A 5-year average of $799411.8 and a median of $472000.0 in 2024 frame the typical range for Treasury Shares.
- On a YoY basis, Treasury Shares climbed as much as 0.0% in 2013 and fell as far as 0.0% in 2013.
- A 5-year view of Treasury Shares shows it stood at $3.8 million in 2013, then changed by 0.0% to $3.8 million in 2014, then changed by 0.0% to $3.8 million in 2015, then changed by 0.0% to $3.8 million in 2016, then changed by 0.0% to $3.8 million in 2017.
- Business Quant data shows SLS's Treasury Shares at $3.8 million in Q3 2017, $3.8 million in Q2 2017, and $3.8 million in Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | 2.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.26 Mn |
| Mar 31, 2026 | 2.26 Mn |
| Dec 31, 2025 | 897,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 1.71 Mn |
| Sep 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 472,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Sep 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Jun 30, 2024 | 644,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Mar 31, 2024 | 738,000.00 |
| Dec 31, 2023 | 338,000.00 |
| Dec 31, 2023 | 338,000.00 |